Products & Services

Our portfolio of services and pharmaceutical products in the U.S. include:
Products
ALKERAN® (melphalan) tablets
ALKERAN® (melphalan) for injection
REVLIMID® (lenalidomide)		Visit the REVLIMID® website
THALOMID® (thalidomide)		Visit the THALOMID® website
VIDAZA® (azacitidine for injection)		Visit the VIDAZA® website
Services
LifebankUSA (placental and cord blood banking)		Visit the LifebankUSA website
ALKERAN® is a registered trademark of GlaxoSmithKline. REVLIMID®, THALOMID®, VIDAZA® are registered trademarks of Celgene Corporation.

These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed in Locations under About Us).

This site is intended for U.S. Audiences Only ©2005-2007, Celgene Corporation Disclaimer  |  Terms of Use